MEDICAID PATIENTS ACCESS TO NEW DRUGS

被引:15
作者
GRABOWSKI, H
机构
关键词
D O I
10.1377/hlthaff.7.5.102
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
引用
收藏
页码:102 / 114
页数:13
相关论文
共 9 条
[1]  
EISMAN M, 1981, RES MANAGEMENT JAN, P18
[2]  
GRABOWSKI H, 1986, AM ECON REV, V76, P195
[3]  
GRABOWSKI H, 1983, REGULATION PHARM BAL, P51
[4]  
GRABOWSKI H, 1982, MANAGERIAL DECISION, V3
[5]   A CLOSER LOOK AT THE RETURNS AND RISKS OF PHARMACEUTICAL RESEARCH-AND-DEVELOPMENT [J].
JOGLEKAR, P ;
PATERSON, ML .
JOURNAL OF HEALTH ECONOMICS, 1986, 5 (02) :153-177
[6]   THE SOCIAL DRUG LAG - AN EXAMINATION OF PHARMACEUTICAL APPROVAL DELAYS IN MEDICAID FORMULARIES [J].
SCHWEITZER, SO ;
SALEHI, H ;
BOLING, N .
SOCIAL SCIENCE & MEDICINE, 1985, 21 (10) :1077-1082
[7]  
1988, AM DRUGGIST MAY
[8]  
1984, NATIONAL PHARM COUNC
[9]  
DEHAEN SURVEY NEW DR